Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies

Journal of Clinical Rheumatology

Volumn 7, Issue 5, 2001, Pages 326-331

  Ubogu, Eroboghene E ^a   Zaidat, Osama O ^a   Suarez, José I ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticardiolipin antibodies; Axonal neuropathy; Guillian Barr syndrome; Polyradiculoneuropathy; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INTENSIVE CARE UNIT; MOTOR NEUROPATHY; NERVE REGENERATION; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; SENSORY NEUROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034763281     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200110000-00014     Document Type: Article

References (36)

1. Systemic lupus erythematosus
2. The natural history of systemic lupus erythematosus by prospective analysis
3. Neuropsychiatric manifestations of systemic erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease
4. Peripheral neuropathy in systemic lupus erythematosus
5. Peripheral neuropathy in systemic lupus erythematosus
6. Anterior radiculopathy of lupus erythematosus cells: Report of case
7. Polyneuritis with albuminocytologic dissociation in the spinal fluid in systemic lupus erythematosus
8. Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy
9. Acute polyradiculopathy complicating systemic lupus erythematosus
10. A case of systemic lupus erythematosus presenting as Guillian-Barré syndrome
11. Polyneuritis in systemic lupus erythematosus. Review of the literature and report of a case
12. An acute axonal form of Guillian-Barré polyneuropathy
13. Severe axonal degeneration in acute Guillian-Barré syndrome: Evidence of two different mechanisms?
14. Pathology of the motor-sensory axonal Guillian-Barré syndrome
15. Guillian-Barré syndrome in northern China: The spectrum of neuropathologic changes in clinically defined cases
16. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillian-Barré syndrome
17. Guillian-Barré syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
18. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
19. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China
20. The Guillian-Barré syndrome
21. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillian-Barré syndrome
22. The 1982 revised criteria for the classification of systemic lupus erythematosus
23. Patterns of recovery in the Guillian-Barré syndromes
24. A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology
25. Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA Class II gene associations. European concerted action on the immunogenetics of SLE
26. Antiglycolipid autoantibody detected in the sera of systemic lupus erythematosus patients
27. Serum antibodies to gangliosides in systemic lupus erythematosus
28. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies
29. Autoantibodies to phospholipids and brain extract in patients with the Guillian-Barré syndrome: Cross-reactive or pathogenic?
30. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillian-Barré syndrome
31. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments m Guillian-Barré syndrome
32. The use of intravenous immunoglobulin in Miller-Fisher syndrome
33. Idiopathic dysautonomia treated with intravenous gamma-globulin
34. Treatment of acute pandysautonomia with intravenous immunoglobulin
35. Systemic lupus erythematosus and related conditions. Chapter 11
36. Central nervous system disease in systemic lupus erythematosus: Therapy and prognosis